Plaque Psoriasis

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses the unmet needs of patients with psoriasis.

In this video, Matthew Lewis, MD, MPH, clinical associate professor, of dermatology at Standford University, discusses the latest treatment advancements for psoriasis.

Patients with atopic dermatitis and plaque psoriasis who were treated with a topical phosphodiesterase 4 inhibitor exhibited significant improvement, according to a study.

Vtama cream 1% may be used in combination with an injectable biologic for the treatment of plaque psoriasis, according to a Schweiger Dermatology Group press release.

Arcutis reported its financial results for the third quarter of 2023, which included a total revenue of $38.1 million and a 70% increase in Zoryve revenue, according to a company press release.

While certain demographic factors were associated with a higher risk for paradoxical eczema among patients with psoriasis, treatment with certain biologic classes was not, according to a study.

In new phase 4 results, Vtama cream 1% demonstrated strong, rapid efficacy for the treatment of adults with plaque psoriasis in the head and neck, Dermavant announced in a press release.